Results for tag: "Proliferative Vitreoretinopathy Drug"

Proliferative Vitreoretinopathy (PVR) is a disorder of the retina that can lead to vision loss. It is caused by the growth of abnormal tissue on the surface of the retina, which can lead to retinal detachment. Treatment for PVR typically involves the use of drugs to reduce the growth of abnormal tissue and to prevent further retinal detachment. Optical Disorders Drugs are used to treat PVR and other retinal diseases. These drugs are typically administered via intravitreal injections, which are injections directly into the vitreous cavity of the eye. Common drugs used to treat PVR include anti-VEGF agents, corticosteroids, and immunomodulators. The Proliferative Vitreoretinopathy Drug market is a rapidly growing segment of the Optical Disorders Drugs market. Companies in this market are focused on developing and commercializing drugs to treat PVR and other retinal diseases. Some of the major companies in this market include Regeneron Pharmaceuticals, Allergan, Novartis, Roche, and Bayer. Show Less Read more